7 July 2014

Singapore Exchange Limited Tepid securities market activity

Neutral

Rating:

(Maintained at Neutral)

SINGAPORE | INVESTMENT SERVICES | UPDATE 



 

Securities Daily Average Value (SDAV) saw a slight recovery of 3.5% q-q to S1.125 but trade volumes remain suppressed with SDAV down 30.1% y-y based on SGX figures. Securities activity levels are persistently lower than expected and we see limited drivers in the near-term, leading us to revise our FY15 forecasted SDAV downwards. The “SGX Market Maker and Liquidity Provider Programme” has been available since 1 Jun 14. Market makers and liquidity providers are incentivized through clearing fee rebates and depending on if they are price-taking/making in nature. Rebates can potentially reduce clearing fees to zero for market makers (more stringent criterions and commitment) and up to 75% for liquidity providers. In our view, this would likely boost liquidity and encourage trade volumes but success hinges on the number and quality of market participants. Other micro-structural changes like board lot size reduction would also compliment this programme in our opinion. Derivatives Daily Average Volume (DDAV) has shrunk by 8.9% q-q to 0.412 million contracts and 20.2% y-y from an exceptionally strong 4Q13. Maintain at “Neutral”, with a revised Target price of S$7.45 based on revised EPS and PE multiple of 23X FY14 earnings as we roll over our valuations to FY15.

Target Price (SGD) Forecast Dividend (SGD) Closing Price (SGD) Potential Upside

7.45 0.30 6.94 11.7%

Company Description SGX Ltd opera tes a s a n i ntegra ted s ecuri ti es a nd deri va ti ves excha nge i n Si nga pore. Securi ty products i ncl ude equi ti es , bonds , excha nge tra ded funds , wa rra nts , a nd ADRs . Deri va ti ves products i ncl ude futures a nd opti ons , s tructured wa rra nts , a nd extended s ettl ements .

Company Data Raw Beta (Past 2yrs weekly data)

0.85

Market Cap. (USD mn / SGD mn)

What is the news? SGX Ltd will be announcing its FY14 results on 30 Jul 2014. Based on monthly statistics recently released by SGX, 4Q14’s SDAV recovered 3.5% q-q to S$1.125 billion. DDAV shrunk in 4Q14, decreasing 8.9% q-q to 0.412 million contracts.

1.2

Closing Px in 52 week range 6.66

7.70

0%

50%

100%

8.50 8.00 7.50 7.00 6.50 6.00 5.50 5.00

20 15

10 5 0

SGX SP EQUITY

Major Shareholders 1. SEL Hol di ngs Pte Ltd 2. Ja pa n Excha nge Group Inc 3. Va ngua rd Group Inc

Jul-14

Apr-14

Volume, mn

Jan-14

Oct-13

While we expect SDAV and DDAV to pick up in FY15 and FY16 with recoveries in some major markets especially so for US and China, securities activity levels are persistently subdued which pose as a near-term headwind for SGX. Potentially, the introduction of market makers and liquidity providers could serve to increase market volumes but gestation length is unclear at such an early stage. The lack of near-term catalysts to alleviate the low SDAV levels has led us to trim our EPS forecast. We continue to expect the Derivatives business to be a key growth driver in the medium to long term until micro-structural changes in the securities business succeed in lifting volumes. Key re-rating catalyst will be a sustained pick-up in market volumes from external macro drivers and the success of the SGX introduced measures for boosting liquidity, IPOs and take-off of new derivatives products launched.

3M Average Daily T/O (mn)

Jul-13

How do we view this? We expect Securities Revenue to pick up as SDAV has recovered marginally and retail versus institutional mix has been more weighted on retail (67%) implying that clearing fees could be higher q-q. Derivatives Revenue could be slightly lacklustre with the dip in DDAV. The q-q softening in DDAV was largely due to the FTSE China A50 Index Futures (-6.0%) and Nikkei 225 Futures (-26.5%) but mitigated by an increase in the Nifty Index Futures (+16.6%) possibly due to the India elections. For FY14, the key drivers continue to be heavily centred on the Nikkei 225, FTSE China A50, MSCI Taiwan Index and Nifty index contracts.

5955 / 7425

STI rebased

(%) 23.4 4.96 1.69

Valuation Method P/E Mul ti pl e Analyst Benjamin Ong benja mi nongcw@phi l l i p.com.s g +65 65311535

Investment Actions? We revise our FY14 EPS estimates downwards by 3% to S$0.30 and FY15 and FY16 EPS by 6% and 5% respectively. As we rollover our valuations to FY15, we derive a revised TP of S$7.45 and maintain our rating at “Neutral”.

Page | 1 MCI (P) 046/11/2013 Ref. No.: SG2014_0105

Singapore Exchange Limited 7 July 2014 Key Financial Summary FYE FY12 FY13 FY14F FY15F FY16F Revenue (SGD mn) 648 715 688 749 818 NPAT, a dj. (SGD mn) 304 351 320 354 406 EPS, a dj. (SGD) 0.28 0.33 0.30 0.33 0.38 P/E (X),a dj. 24.9 24.1 23.2 20.9 18.3 BVPS (SGD) 0.78 0.83 0.85 0.90 0.96 P/B (X) 8.7 9.1 8.1 7.7 7.2 DPS (SGD) 0.27 0.28 0.27 0.30 0.35 Di v. Yi el d (%) 4.0% 3.7% 3.9% 4.3% 5.0% Source: Bl oomberg, PSR es t. *Forwa rd mul ti pl es a nd yi el ds a re ba s ed on current pri ce a nd hi s tori ca l mul ti pl es a nd yi el ds a re ba s ed on hi s tori ca l pri ce

Focus points Weak securities market activities continue to pose a near-term headwind to SGX Fig: Quarterly SDA Value ($Bil) vs Volume (Bil) 2.00

VAL SDAV

6.0

VOL SDAV (RHS)

5.0

1.50

4.0

1.00

3.0

2.0

0.50

1.0 4Q14

3Q14

2Q14

1Q14

4Q13

3Q13

2Q13

1Q13

4Q12

3Q12

2Q12

1Q12

0.00

-

Source: Company, PSR Fig. YTD Price (LHS) vs SDAV MA ($M) (RHS) 7.90

Price

2,200

SDAV MA

Jun 14

May 14

May 14

Apr 14

Mar 14

Jan 14

600

Jan 14

5.90

Dec 13

1,000

Nov 13

6.40

Oct 13

1,400

Sep 13

6.90

Aug 13

1,800

Jul 13

7.40

Source: Company, PSR

Page | 2

Singapore Exchange Limited 7 July 2014

Expect Derivatives business to be key growth driver in the medium to long-term Fig: Equity Index Futures Contracts volume ('000 contracts)

14,000 12,000 10,000 8,000 6,000 4,000 2,000 -

FTSE China A50 Index Futures

MSCI Taiwan Index Futures

Nikkei 225 Index Futures

SGX S&P CNX Nifty Index Futures

Others

4Q14

3Q14

2Q14

1Q14

4Q13

3Q13

2Q13

1Q13

4Q12

3Q12

2Q12

1Q12

Source: Company, PSR FTSE China A50 Index Futures

4%

MSCI Taiwan Index Futures

30%

22%

Nikkei 225 Index Futures

25%

19%

SGX S&P CNX Nifty Index Futures Others

Source: Company. PSR Fig. Rev by segment (%) vs Total Operating rev ($’000) Securities

Deri vatives

Mark et data

Member svc

Depository svc

Issuer services

Other revenue

22%

23%

25%

25%

28%

28%

28%

28%

29%

28%

32%

32%

39%

41%

37%

40%

35%

37%

36%

40%

38%

38%

32%

32%

4Q11

1Q12

2Q12

3Q12

4Q12

1Q13

2Q13

3Q13

4Q13

1Q14

2Q14

3Q14

Source: Company, PSR

Page | 3

Singapore Exchange Limited 7 July 2014 Fig 1. Securities Revenue

70 60

50 40

30 20

10 2Q13

3Q13

4Q13

1Q14

2Q14

3Q14

2Q13

3Q13

4Q13

1Q14

2Q14

3Q14

2Q13

3Q13

4Q13

1Q14

2Q14

3Q14

1Q13

4Q12

3Q12

2Q12

9 9 9 9 9 8 8 8 8 8

1Q12

Fig 3. Market Data Revenue

-

4Q11

3Q14

2Q14

1Q14

4Q13

3Q13

2Q13

1Q13

4Q12

3Q12

2Q12

1Q12

4Q11

90 80 70 60 50 40 30 20 10 -

Fig 2. Derivatives Revenue

Fig 4. Member services and connectivity

13 12 12

11 11 10 10

2Q12

3Q12

4Q12

1Q13

2Q12

3Q12

4Q12

1Q13

1Q12

Fig 5. Depository services

4Q11

3Q14

2Q14

1Q14

4Q13

3Q13

2Q13

1Q13

4Q12

3Q12

2Q12

1Q12

4Q11

9

Fig 6. Issuer services

30

25

25

20

20

15

15 10

10

Fig 8. Total revenue Securities

250

Member svc

Depository svc

Issuer services

Other revenue

100 50 3Q14

2Q14

1Q14

4Q13

3Q13

2Q13

1Q13

4Q12

3Q12

2Q12

Member svc

1Q12

Market data

4Q11

0

3Q14

2Q14

1Q14

4Q13

3Q13

2Q13

1Q13

4Q12

3Q12

2Q12

1Q12

Deri vatives

Fig 10. Total revenue - Less Securities and Derivatives Depository svc

Issuer services

Other revenue

80

Market data

Member svc

Depository svc

Issuer services

Other revenue

60 40 20 3Q14

2Q14

1Q14

4Q13

3Q13

2Q13

1Q13

4Q12

3Q12

2Q12

1Q12

0

4Q11

3Q14

2Q14

1Q14

4Q13

3Q13

2Q13

1Q13

4Q12

3Q12

2Q12

1Q12

4Q11

120 100 80 60 40 20 0

Market data

150

Fig 9. Total revenue - Less Securities 140

Deri vatives

200

4Q11

1.6 1.4 1.2 1.0 0.8 0.6 0.4 0.2 0.0

1Q12

Fig 7. Other revenue

4Q11

3Q14

2Q14

1Q14

4Q13

3Q13

2Q13

1Q13

4Q12

3Q12

2Q12

-

1Q12

5 4Q11

5 -

Page | 4

Singapore Exchange Limited 7 July 2014 Fig 11. Operating Revenue and NPAT 250

Fig 12. SDAV ($ M ) vs Price

Ops rev ('000)

2,000

NPAT

200

SDAV

8.00

Price (RHS)

7.75

1,500

7.50

150 1,000

7.25

100

6.50

26 Jun

06 Jun

17 May

27 Apr

07 Apr

Fig 13. 1/2 Yr Price Earnings Ratio (TTM)

6.75

18 Mar

-

3Q14

2Q14

1Q14

4Q13

3Q13

2Q13

1Q13

4Q12

3Q12

2Q12

1Q12

4Q11

-

7.00

500

50

Fig 14. 5 yr Price Earnings Ratio (TTM)

23

40 SD + 1

23

22

22.59 22.46

Mea n

22

21.76

21

20.92

35

SD + 1

30

20

SD - 1

Jun 14

Feb 14

Sep 13

May 13

Dec 12

Jul 12

Mar 12

Oct 11

Jun 11

Jan 11

Aug 10

Apr 10

Nov 09

Jul 09

Jul 14

Jun 14

May 14

Apr 14

Mar 14

10

Feb 14

15

20

Jan 14

21

28.42 25.47 22.52 22.52

Mea n

25

Page | 5

Singapore Exchange Limited 7 July 2014 For Financial Summary at the end of report FYE Income Statement (SGD mn) Securi ti es Deri va ti ves Others Operating revenue Opera ti ng expens es Operating profit Other ga i ns /(l os s es ) As s oci a tes & JVs Profit Before Tax Ta xa ti on Net Income, reported Net Income, adj.

FYE Per share data (SGD) EPS, reported EPS, a dj. DPS BVPS

FY12

FY13 FY14F FY15F FY16F

248 163 236 648 284 364 (6) (3) 355 (64) 292 304

270 201 245 715 301 414 (10) 4 408 (72) 336 351

FY12 0.27 0.28 0.27 0.78

FY13 0.31 0.33 0.28 0.83

228 208 252 688 314 373 5 3 381 (61) 320 320

244 246 260 749 329 420 5 4 429 (74) 354 354

277 273 267 818 336 482 5 4 491 (85) 406 406

FY14F FY15F FY16F 0.30 0.30 0.27 0.85

0.33 0.33 0.30 0.90

FYE Balance Sheet (SGD mn) PPE Softwa re AFS i nves tments Others Total non-current assets Recei va bl es Ca s h Others Total current assets Total Assets Pa ya bl es Others Total current liabilities Total non-current liabilities Total Liabilities Shareholder Equity

FY12

FYE Valuation Ratios P/E (X), a dj. P/B (X) Di vi dend Yi el d (%) Growth & Margins (%) Growth Securi ti es Revenue Deri va ti ves Revenue Revenue Net Income, a dj. Margins Net profi t ma rgi n Core profi t ma gi n Key Ratios ROE (%) ROA (%) Di vi dend Pa yout ra ti o Cos t to Income

FY12

26 119 66 6 217 779 698 35 1,512 1,729 796 78 874 22 896 833

FY13 24 112 51 28 215 757 763 60 1,580 1,794 783 100 884 22 906 889

FY14F FY15F FY16F 17 113 51 29 210 825 738 60 1,623 1,833 784 115 899 21 921 913

12 116 52 33 214 899 788 60 1,747 1,960 854 115 969 21 991 970

10 110 54 37 212 981 846 60 1,888 2,099 932 115 1,048 21 1,069 1,030

0.38 0.38 0.35 0.96

FYE FY12 FY13 FY14F FY15F FY16F Cashflow Statements (SGD mn) CFO PBT 355 408 381 429 491 Adjus tments 53 56 72 46 65 WC cha nges (9) 6 (68) (4) (4) Ca s h genera ted from ops 399 470 386 471 553 Ta xes pa i d, net (57) (52) (61) (74) (85) Cashflow from ops 342 419 324 397 467 CFI CAPEX, net (51) (28) (50) (50) (64) Others 6 (12) 0 0 0 Cashflow from investments (45) (40) (50) (50) (64) CFF Di vi dends (288) (289) (300) (297) (346) Others (5) (25) 0 0 0 Cashflow from financing (293) (314) (300) (297) (346) Net change in cash 5 65 (25) 50 58 CCE, end 548 613 588 638 696 Source: Compa ny Da ta , PSR es t

24.9 8.7 4.0%

FY13 24.1 9.1 3.7%

FY14F FY15F FY16F 23.2 8.1 3.9%

20.9 7.7 4.3%

18.3 7.2 5.0%

-14.0% 8.5% -15.4% 6.8% 13.8% 15.0% 23.1% 3.4% 18.5% 11.2% -1.9% 10.4% -3.8% 8.9% 9.2% -2.5% 15.5% -8.8% 10.8% 14.6% 44.6% 46.6% 46.2% 47.0% 49.4% 46.5% 48.7% 46.2% 47.0% 49.4% 36.7% 40.8% 35.5% 37.7% 40.6% 16.7% 19.9% 17.6% 18.7% 20.0% 95% 85% 90% 91% 92% 43.8% 42.1% 45.7% 43.9% 41.0%

Page | 6

Singapore Exchange Limited 7 July 2014 Ratings History 9.00

Market Price

8.50

Target Price

Source: Bloomberg, PSR

8.00 7.50 7.00 6.50 6.00 5.50 5.00 Jun-15

Mar-15

Dec-14

Sep-14

Jun-14

Mar-14

Dec-13

Sep-13

Jun-13

Mar-13

Dec-12

Sep-12

Jun-12

1 2 3 4 5

PSR Rating System Total Returns Recommendation Rating > +20% Buy 1 +5% to +20% Accumul a te 2 -5% to +5% Neutra l 3 -5% to -20% Reduce 4 < -20% Sel l 5 Remarks We do not ba s e our recommenda tions entirel y on the a bove qua ntitative return ba nds . We cons i der qua l i tative fa ctors l i ke (but not l i mi ted to) a s tock's ri s k rewa rd profi l e, ma rket s entiment, recent ra te of s ha re pri ce a ppreci a tion, pres ence or a bs ence of s tock pri ce ca tal ys ts , a nd s pecul a tive undertones s urroundi ng the s tock, before ma ki ng our fi na l recommenda tion

Page | 7

Singapore Exchange Limited 7 July 2014 Important Information This publication is prepared by Phillip Securities Research Pte Ltd., 250 North Bridge Road, #06-00, Raffles City Tower, Singapore 179101 (Registration Number: 198803136N), which is regulated by the Monetary Authority of Singapore (“Phillip Securities Research”). By receiving or reading this publication, you agree to be bound by the terms and limitations set out below. This publication has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this document by mistake, please delete or destroy it, and notify the sender immediately. Phillip Securities Research shall not be liable for any direct or consequential loss arising from any use of material contained in this publication. The information contained in this publication has been obtained from public sources, which Phillip Securities Research has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this publication are based on such information and are expressions of belief of the individual author or the indicated source (as applicable) only. Phillip Securities Research has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete, appropriate or verified or should be relied upon as such. Any such information or Research contained in this publication is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the preparation or issuance of this report, (i) be liable in any manner whatsoever for any consequences (including but not limited to any special, direct, indirect, incidental or consequential losses, loss of profits and damages) of any reliance or usage of this publication or (ii) accept any legal responsibility from any person who receives this publication, even if it has been advised of the possibility of such damages. You must make the final investment decision and accept all responsibility for your investment decision, including, but not limited to your reliance on the information, data and/or other materials presented in this publication. Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this material are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this publication is not indicative of future results. This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This publication should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this publication has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this material is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this publication involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks. Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this research should take into account existing public information, including any registered prospectus in respect of such product. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the preparation or issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the preparation or issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this publication, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the preparation or issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this publication. Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the preparation or issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment. To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the preparation or issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold a interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this publication. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the preparation or issuance of this report, which is not reflected in this material, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the preparation or issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the preparation or issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this material. The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.

Page | 8

Singapore Exchange Limited 7 July 2014 Section 27 of the Financial Advisers Act (Cap. 110) of Singapore and the MAS Notice on Recommendations on Investment Products (FAA-N01) do not apply in respect of this publication. This material is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this material may not be suitable for all investors and a person receiving or reading this material should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products. Please contact Phillip Securities Research at [65 65311240] in respect of any matters arising from, or in connection with, this document. This report is only for the purpose of distribution in Singapore. Contact Information (Singapore Research Team) Management Chan Wai Chee (CEO, Research - Special Opportunities) Joshua Tan (Head, Research - Equities & Macro) Equities | Macro Joshua Tan Soh Lin Sin

+65 6531 1249 +65 6531 1516

Finance Benjamin Ong

+65 6531 1535

Telecoms Colin Tan

+65 6531 1221 SINGAPORE Phillip Securities Pte Ltd Raffles City Tower 250, North Bridge Road #06-00 Singapore 179101 Tel +65 6533 6001 Fax +65 6535 6631 Website: www.poems.com.sg

General Enquiries Research Assistant

+65 6531 1240

Market Analyst | Equities Kenneth Koh +65 6531 1791

US Equities Wong Yong Kai

+65 6531 1685

Real Estate Caroline Tay

Real Estate Lucas Tan

+65 6531 1229

+65 6531 1231 +65 6531 1249

+65 6531 1792

Transport Richard Leow, CFTe +65 6531 1735 Contact Information (Regional Member Companies) MALAYSIA Phillip Capital Management Sdn Bhd B-3-6 Block B Level 3 Megan Avenue II, No. 12, Jalan Yap Kwan Seng, 50450 Kuala Lumpur Tel +603 2162 8841 Fax +603 2166 5099 Website: www.poems.com.my

HONG KONG Phillip Securities (HK) Ltd 11/F United Centre 95 Queensway Hong Kong Tel +852 2277 6600 Fax +852 2868 5307 Websites: www.phillip.com.hk

JAPAN Phillip Securities Japan, Ltd. 4-2 Nihonbashi Kabuto-cho Chuo-ku, Tokyo 103-0026 Tel +81-3 3666 2101 Fax +81-3 3666 6090 Website:www.phillip.co.jp

INDONESIA PT Phillip Securities Indonesia ANZ Tower Level 23B, Jl Jend Sudirman Kav 33A Jakarta 10220 – Indonesia Tel +62-21 5790 0800 Fax +62-21 5790 0809 Website: www.phillip.co.id

CHINA Phillip Financial Advisory (Shanghai) Co Ltd No 550 Yan An East Road, Ocean Tower Unit 2318, Postal code 200001 Tel +86-21 5169 9200 Fax +86-21 6351 2940 Website: www.phillip.com.cn

THAILAND Phillip Securities (Thailand) Public Co. Ltd 15th Floor, Vorawat Building, 849 Silom Road, Silom, Bangrak, Bangkok 10500 Thailand Tel +66-2 6351700 / 22680999 Fax +66-2 22680921 Website www.phillip.co.th

FRANCE King & Shaxson Capital Limited 3rd Floor, 35 Rue de la Bienfaisance 75008 Paris France Tel +33-1 45633100 Fax +33-1 45636017 Website: www.kingandshaxson.com

UNITED KINGDOM King & Shaxson Capital Limited 6th Floor, Candlewick House, 120 Cannon Street, London, EC4N 6AS Tel +44-20 7426 5950 Fax +44-20 7626 1757 Website: www.kingandshaxson.com

UNITED STATES Phillip Futures Inc 141 W Jackson Blvd Ste 3050 The Chicago Board of Trade Building Chicago, IL 60604 USA Tel +1-312 356 9000 Fax +1-312 356 9005

AUSTRALIA PhillipCapital Level 12, 15 William Street, Melbourne, Victoria 3000, Australia Tel +61-03 9629 8288 Fax +61-03 9629 8882 Website: www.phillipcapital.com.au

SRI LANKA Asha Phillip Securities Limited No 10, Prince Alfred Tower, Alfred House Gardens, Colombo 3, Sri Lanka Tel: (94) 11 2429 100 Fax: (94) 11 2429 199 Website: www.ashaphillip.net/home.htm

INDIA PhillipCapital (India) Private Limited No. 1, C‐Block, 2nd Floor, Modern Center , Jacob Circle, K. K. Marg, Mahalaxmi Mumbai 400011 Tel: (9122) 2300 2999 Fax: (9122) 6667 9955 Website: www.phillipcapital.in

Page | 9

Singapore Exchange Ltd - PhillipCapital

Jul 7, 2014 - securities business succeed in lifting volumes. Key re-rating catalyst ... Analyst. Benjamin Ong [email protected]. +65 65311535.

434KB Sizes 38 Downloads 421 Views

Recommend Documents

Singapore Exchange Ltd - Another Positive Catalyst
Feb 7, 2018 - New Zealand Stock. Exchange. NZX NZ NR NZD 214.5. 1.10. N.A. 32.4 19.0 16.9 24.1 4.2 4.4 4.3 19.2 21.7 24.1 5.5 5.5. 5.8. Asia Pac Weighted. Avg (incl ..... Internet & Telcos. Ning MA, CFA. (852) 2268 0672 [email protected]. • Insu

starhub ltd - PhillipCapital
Feb 26, 2015 - Website: www.phillipcapital.com.au ... You must make the final investment decision and accept all ... as authoritative, without further being subject to the recipient's own independent verification ... exchange rates between US dollars

Singapore Exchange Ltd - Another Positive Catalyst
Feb 7, 2018 - SGX announced that it will be collaborating with Bursa Malaysia (BM) to jointly develop a BM-SGX stock market trading link by end 2018. This link will enable investors to trade and settle the shares listed on both markets more efficient

SMRT Corp Ltd - PhillipCapital
Feb 4, 2015 - 1,231. 1,279. NP A T, adj (SGD mn). 101. 62. 93. 104. EP S, adj. (Cents). 5.50. 4.07. 6.10. 6.82. P /E, adj. (x). 23.0. 26.4. 29.5. 26.4. B VP S (Cents). 50.54. 52.69. 56.56. 60.04 ..... Past performance of any product referred to in th

starhub ltd - PhillipCapital
Feb 26, 2015 - surrounding the stock, before making our final recommendation .... Website: www.phillipcapital.com.au ... as authoritative, without further being subject to the recipient's own independent verification and exercise of judgment.

SMRT Corp Ltd - PhillipCapital
Feb 4, 2015 - 1,231. 1,279. NP A T, adj (SGD mn). 101. 62. 93. 104. EP S, adj. (Cents). 5.50. 4.07. 6.10. 6.82. P /E, adj. (x). 23.0. 26.4. 29.5. 26.4. B VP S (Cents). 50.54. 52.69. 56.56. 60.04 ..... Past performance of any product referred to in th

Valuetronics Holding Ltd. Buy - PhillipCapital
Jun 20, 2014 - We think their formalization of a dividend policy is a good first sign of ... we are only taking 60% of net cash into our value consideration, and ... through the years to become more than an integrated EMS provider with ... manufactur

Singapore Exchange (SGXL.SI)
supported by securities +2%qoq, market data +1%qoq and issuer services .... (positive); 3) Global sector re-rating/M&A: Our current view is that a cross-border ... accurately reflect their personal views about each issuer and security referenced ....

Singapore Exchange Limited
Depository svc. Issuer services ... Depository svc. Issuer services ... 55. Derivatives. 163. 201. 209. 290. 299. Software. 119. 112. 112. 131. 119. Others. 236. 245.

DBS Group Holdings Ltd - KGI Securities (Singapore)
Oct 24, 2011 - Net interest margin (NIIM) jumped 6bp qoq from 1.69% in 1QFY15 to reach. 1.75% in ... Investment banking also saw a record quarter as DBS completed nine significant deals which ... Source: Company Data, KGI Fraser. Buy.

raffles medical group ltd - Singapore - InvestingNote
Mar 4, 2015 - receiving non-critical ambulance cases from mid-2015. Construction works on both hospital extension and the new commercial mall projects is ...

Valuetronics - PhillipCapital
Jun 20, 2014 - continue to benefit from the outsourcing trend in manufacturing. ... would grow to EUR 905m by 2016 implying a double digit CAGR. Instead of double digit ..... Cyclical nature of new lighting installation with the business cycle.

singapore o&g ltd (sog sp) buy
Well-positioned within the healthcare sector, where market dynamics for private .... The main bulk of these expenses involve investment in medical equipment .... between the group and the specialists as most of them have equity in SOG.

Global Logistics Properties - PhillipCapital
Feb 6, 2015 - Website: www.poems.com.sg .... investment decision and accept all responsibility for your investment decision, ... related futures or options, purchase or sell, make a market in, ... fluctuation in exchange rates between US dollars and

Global Logistics Properties - PhillipCapital
Feb 6, 2015 - Strengthen recurring income with augmented fund management platform. Expected US ... Fund management business to gain traction – GLP has identified fund management platform ..... Websites: www.phillip.com.hk. JAPAN.

Resumption of the downtrend - PhillipCapital
Nov 3, 2015 - The 3rd attempt was the strongest of all as price managed to close above the 200 MA for roughly 18 days before the Bearish ... London, EC4N 6AS. Tel +44-20 7426 5950. Fax +44-20 7626 1757. Website: www.kingandshaxson.com. UNITED STATES.

LIC Housing Finance - PhillipCapital
Apr 2, 2014 - It will be able to scale up its developer book only by FY16. ..... Ap r-12. Oct-12. Ap r-13. Oct-13. Ap r-14. P/BV Discount (LICHF / HDFCHF).

Soilbuild Business Space REIT - PhillipCapital
Oct 15, 2015 - We tuned in to the Analyst Briefing conference call earlier this morning. SBREIT will trade ex-dividend on 20 October. Results at a glance.

Soilbuild Business Space REIT - PhillipCapital
Oct 15, 2015 - Source: Company, Phillip Securities Research (Singapore) ... Solaris, who are from the IT-sector of software development and games. ..... Investments will be denominated in various currencies including US dollars and Euro ...

national stock exchange of india limited - Agri-Tech (India) Ltd.
Jan 24, 2014 - per SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20,. 2012. This circular shall be effective from January 28, ...

NATIONAL STOCK EXCHANGE OF INDIA LTD. DEPARTMENT ... - NSE
Sep 19, 2016 - NATIONAL STOCK EXCHANGE OF INDIA LTD. ... In pursuance of Regulation 3.1.1 of the National Stock Exchange ... Face Value (In Rs.) 2.

NATIONAL STOCK EXCHANGE OF INDIA LTD. DEPARTMENT ... - NSE
Oct 19, 2016 - NATIONAL STOCK EXCHANGE OF INDIA LTD. ... In pursuance of Regulation 3.1.1 of the National Stock Exchange ... Face Value (In Rs.) 10.

February 19,2018 The National Stock Exchange of India Ltd ... - Religare
Feb 19, 2018 - ··RELIGARE. _. Values that bind. Press Statement. RELIGARE ENTERPRISES TO RAISE INR 916 CRORE THROUGH PREFERENTIAL ISSUE.